Geneos Wealth Management’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Geneos Wealth Management’s Portfolio TSPA Stock Details TSPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.9M	Sell	495,707 -2,283	-0.5%	-$109K	0.45%	49
2026 Q2	$23.7M	Sell	497,990 -801	-0.2%	-$36.7K	0.48%	47
2026 Q1	$20.4M	Buy	498,791 +2,161	+0.4%	+$92.3K	0.47%	46
2025 Q4	$21.2M	Buy	496,630 +17,736	+4%	+$754K	0.52%	40
2025 Q3	$20.1M	Buy	478,894 +9,980	+2%	+$402K	0.51%	40
2025 Q2	$18.2M	Buy	468,914 +9,472	+2%	+$341K	0.45%	48
2025 Q1	$16.2M	Buy	459,442 +459,210	+197,935%	+$17M	0.54%	34
2024 Q4	$8.58K	Buy	+232	New	+$8.61K	﹤0.01%	2110

Other funds holding TSPA

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Forvis Mazars Wealth Advisors Springfield, Missouri $6.09B AUM 14.51% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Provident Wealth Management Brentwood, Tennessee $282M AUM 14.55% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Frontier Asset Management Sheridan, Wyoming $530M AUM 13.97% 1-Year Est. Return

Prodigy Asset Management Omaha, Nebraska $335M AUM 5.94% 1-Year Est. Return

First National Trust Hermitage, Pennsylvania $2.88B AUM 20.17% 1-Year Est. Return

Henderson Brothers Financial Partners Pittsburgh, Pennsylvania $276M AUM

Geneos Wealth Management's TSPA Position: Q3 2026 in Review

Geneos Wealth Management reduced its T. Rowe Price US Equity Research ETF (TSPA) stake by 0.46% in Q3 2026, selling an estimated $109K and leaving 495,707 shares worth $23.9M. The position accounts for 0.45% of the portfolio, ranked #49.

Geneos Wealth Management first reported a position in TSPA in Q4 2024 and has held it in 8 quarters since. 83 funds tracked by Wall St. Rank hold TSPA as of Q3 2026.

Geneos Wealth Management held 495,707 shares of T. Rowe Price US Equity Research ETF worth $23.9M as of Q3 2026.
Geneos Wealth Management sold 2,283 T. Rowe Price US Equity Research ETF shares in Q3 2026, an estimated $109K.
T. Rowe Price US Equity Research ETF made up 0.45% of Geneos Wealth Management's portfolio in Q3 2026, its #49 holding.
Geneos Wealth Management first reported a position in T. Rowe Price US Equity Research ETF in Q4 2024 and has held it in 8 quarters since.
83 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.